
News|Articles|January 19, 2026
Respiratory Vaccination by the Numbers: COVID-19, Flu, and RSV
Author(s)Maggie L. Shaw
Fact checked by: Giuliana Grossi
The CDC reveals current vaccination trends for COVID-19, flu, and RSV during the 2025-2026 respiratory virus season, highlighting public adoption rates.
Advertisement
Advertisement
In the midst of
Related to this article

Faculty say heart failure patients miss iron deficiency care when no one owns it; pharmacist-led workflows may help close the gap.

The FDA approved cemdisiran (Livsayis; Regeneron), a subcutaneous siRNA dosed every 3 months, for AChR-positive generalized myasthenia gravis.

In a single-clinic study, 61.5% of patients with psoriasis screened positive for psoriatic arthritis using a validated questionnaire.

CRC diagnoses after endoscopic mucosal resection (EMR) were uncommon in a real-world cohort, though racial and ethnic differences remain unclear.

Infectious disease and urology clinicians described unclear treatment goals, infusion limits, and access barriers for newer UTI agents.

New ACACIA-HCM analyses at HCMS 2026 add imaging and quality-of-life data as Cytokinetics readies an FDA filing in nonobstructive HCM.

An oral SERD plus everolimus cut the risk of progression or death by 62% in ESR1-mutated advanced breast cancer.
Advertisement
Advertisement

